BIOBASED CHEMICALS
• Bioplastics building blocks( more accurately, sub-units and precursors) that can feed into broader materials innovation
For formulators and manufacturers, yeast-based, nature-identical compounds can be positioned as a double-win, with sustainability and procurement in mind. Yeast-based solutions can reduce reliance on environmentally fragile botanical supply chains, limit the waste associated with certain chemical synthesis routes and improve lot-to-lot consistency by tightly controlling the process conditions.
While the term‘ bioengineering’ sometimes triggers immediate questions about GMOs, the industry reality is more nuanced: in many instances, the yeast-as-production organism is removed during downstream purification, so the final ingredient would contain the nature-identical molecule and be free of yeast. In other words, the yeast acts solely as the manufacturing method, helping companies bridge performance, sustainability and consumer expectations.
Peptides
If yeast-produced plant-derived aromatic and bioactive compounds showcase yeast as a speciality chemical factory, peptides demonstrate its capability as a precision biomanufacturer for highvalue functional molecules. While they are far smaller than a protein, peptides can deliver specific biological
or functional effects, which is why they are increasingly sought after across personal care, wellness and adjacent sectors.
In the personal care world, peptides with anti-ageing, skin appearance, hair and scalp support and other performance cosmetic claims are already associated with premium positioning. Demand is rising but production can be challenging. Chemical synthesis routes are expensive and waste-intensive, whereas biological systems only require fine-tuning to produce the desired peptide cleanly and efficiently.
This is where a plug-and-play approach becomes powerful: engineered yeast chassis strains can be optimised as a reusable platform for producing many different peptides independently with similar manufacturing logic. Once the chassis strain is established with robust expression systems, secretion or recovery methods and downstream processing, new peptides can be easily swapped in, accelerating product development cycles.
The economic appeal is also clear. Compared with commodity food ingredients, peptides for premium cosmetics and personal care products can support higher margins, which helps justify investment in strain development and production scaleup. With peptides sitting in a broad innovation zone that straddles cosmetics, wellness, and in some cases pharma-adjacent applications, they
No treatment
Treatment
Figure 1- Kill graph of Colorado potato beetle on benchtop are attractive targets for companies seeking differentiated products and defensible IP.
Beyond topical personal care, small peptides are also gaining attention in health and wellness for their roles in satiety, metabolism, gut health and other emerging consumer trends. While application specifics vary widely, the larger pattern is consistent with the discovery of new peptide sequences bearing specific functionality, followed by industry-scale production and incorporation into trendsetting products.
RNAi biopesticides
Renaissance’ s most commercial-ready application for its yeast technology is for the development of RNAi-based biopesticides. RNAi is a natural, highly precise and efficient biological mechanism found in plants, animals and fungi that turns off, or‘ silences’, a specific gene.
When the target insects take up the RNAi bioactive against a gene important for feeding, locomotion, fecundity or other essential biological functions, they exhibit severe physiological changes that cause lethality. RNAi-based biopesticides offer a highly targeted approach to pest control, reducing reliance on broad-spectrum synthetic chemical pesticides that are often harmful to other insects, animals, human and plants.
The commercialisation of RNAi biopesticides faces two major hurdles: the high cost of manufacturing bioactives at scale; and the fragility of double-stranded RNA molecules. These degrade easily in real-world conditions, such as UV exposure, moisture, environmental nucleases and temperature swings, often requiring expensive synthetic carriers or protective formulations. A yeast-based RNAi biopesticides technology that significantly lowers both hurdles could be a game-changer here.
The core innovation is elegantly simple: the yeast produces the bioactives and keeps them inside the cell, where they are naturally
MAR / APR 2026 SPECCHEMONLINE. COM
59